Sperotto, A.; Bochicchio, M.T.; Simonetti, G.; Buccisano, F.; Peccatori, J.; Piemontese, S.; Calistri, E.; Ciotti, G.; Pierdomenico, E.; De Marchi, R.;
et al. Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing. Biomedicines 2023, 11, 359.
https://doi.org/10.3390/biomedicines11020359
AMA Style
Sperotto A, Bochicchio MT, Simonetti G, Buccisano F, Peccatori J, Piemontese S, Calistri E, Ciotti G, Pierdomenico E, De Marchi R,
et al. Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing. Biomedicines. 2023; 11(2):359.
https://doi.org/10.3390/biomedicines11020359
Chicago/Turabian Style
Sperotto, Alessandra, Maria Teresa Bochicchio, Giorgia Simonetti, Francesco Buccisano, Jacopo Peccatori, Simona Piemontese, Elisabetta Calistri, Giulia Ciotti, Elisabetta Pierdomenico, Roberta De Marchi,
and et al. 2023. "Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing" Biomedicines 11, no. 2: 359.
https://doi.org/10.3390/biomedicines11020359
APA Style
Sperotto, A., Bochicchio, M. T., Simonetti, G., Buccisano, F., Peccatori, J., Piemontese, S., Calistri, E., Ciotti, G., Pierdomenico, E., De Marchi, R., Ciceri, F., & Gottardi, M.
(2023). Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing. Biomedicines, 11(2), 359.
https://doi.org/10.3390/biomedicines11020359
